Alloimmune Platelet Refractoriness

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2019-01-03
Clinical Trial Update: Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia [Phase 2]
Phase 2 trial investigating eculizumab, a complement inhibitor, to overcome platelet transfusion refractoriness in patients with severe thro…